Genecis Bioindustries
PrivateLast Round
Series A
Extension
Mar 1, 2023
Est. Valuation
$2.14M
Total Funding Raised
$14.83M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Genecis Bioindustries operates in Energy & Sustainability and is based in Toronto. Its latest recorded funding round was a Series A Extension round in March 2023.
Genecis Bioindustries is a biotechnology company that converts organic waste into high-performance, biodegradable polyhydroxyalkanoate (PHA) bioplastics.
Sector
Energy & Sustainability
Verticals
Sustainable Materials, Biotechnology, Circular Economy, Clean Manufacturing, Waste Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genecis Bioindustries Comparables
Compare Genecis Bioindustries with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TerraVerdae Bioworks | 86% | |
| Mango Materials | 85% | |
| Dionymer | 85% |
For institutional investors. Book with your work email.
Genecis Bioindustries Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 1, 2023 | ||||
| Debt | Aug 4, 2022 | ||||
| Series A | Aug 4, 2022 | ||||
| Grant | Jul 27, 2021 | ||||
| Accelerator | Mar 1, 2020 | ||||
Grant | Jan 2, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Genecis Bioindustries Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IT-Farm Corporation | Series A |
| Khosla Ventures | Series A Extension, Series A |
| Business Development Bank of Canada (BDC Capital) | Series A Extension |
| Re:food | Series A |
| Emerald Technology Ventures | Series A Extension |
| BDC Capital | Series A, Series A Extension |
| Government of Canada | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 219% MoM, reaching 2.4K.
- Jun 20, 2026
Monthly visitors increased 391% MoM.
For institutional investors. Book with your work email.
Genecis Bioindustries Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genecis Bioindustries's valuation, stock price, and market status.
Is Genecis Bioindustries a public or private company?
Genecis Bioindustries is a private company.
What is the current stock price of Genecis Bioindustries?
Genecis Bioindustries is a private company, so its shares have no public market price. Caplight tracks Genecis Bioindustries's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genecis Bioindustries worth (valuation)?
Genecis Bioindustries's valuation is estimated at $2.1M based on funding round data.
Can I buy Genecis Bioindustries stock?
Genecis Bioindustries shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genecis Bioindustries's last funding round?
Genecis Bioindustries's most recent funding round was Series A Extension on March 1, 2023.
Who are the main investors in Genecis Bioindustries?
Key investors in Genecis Bioindustries include Khosla Ventures, BDC Capital, Government of Canada, Y Combinator, Next Generation Manufacturing Canada (NGen).
Will Genecis Bioindustries IPO soon?
No public IPO plans have been announced for Genecis Bioindustries.
How can I track Genecis Bioindustries secondary market activity?
Caplight tracks bids, offers, and trades in Genecis Bioindustries's shares on secondary markets.